Boule Diagnostics AB (publ) (STO:BOUL)

Market Cap	261.74M
Revenue (ttm)	515.86M
Net Income (ttm)	-319.68M
Shares Out	38.83M
EPS (ttm)	-8.28
PE Ratio	n/a
Forward PE	7.08
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,748,750
Average Volume	111,388
Open	9.28
Previous Close	10.30
Day's Range	6.58 - 9.30
52-Week Range	6.50 - 10.60
Beta	0.35
RSI	30.03
Earnings Date	Jul 18, 2025

About Boule Diagnostics AB

Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, Medonic, and Quintus brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1956
• Employees: 200
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BOUL